In recent years, medicine has made significant progress in the diagnosis and treatment of Alzheimer’s disease, offering new possibilities to improve the quality of life for patients and their families.
At Medical Arts Neurology, these developments are already part of daily practice and are complemented by a comprehensive and human-centered approach to neurological care.
Among the most important tools is the amyloid PET scan, an advanced imaging test that detects abnormal protein buildup in the brain—a key sign of Alzheimer’s. This technology, recently approved by Medicare and other insurers, has increased diagnostic accuracy to up to 95%, allowing for more precise diagnoses in the early stages.
Since 2024, an innovative blood test—p-tau 217—has also become available. This highly specific biomarker detects molecular changes associated with Alzheimer’s. Less invasive than imaging studies, the test can be used after a cognitive evaluation suggests memory issues or other impairments. Its availability in common clinical labs marks a milestone in early diagnostic access.
On the treatment front, new anti-amyloid medications have been approved that act on the progression of the disease. While not curative, they help slow cognitive decline, providing patients with more functional years and greater autonomy.
Early recognition of mild cognitive impairment—especially episodic memory loss—is essential. Frequent forgetfulness of recent personal events, difficulty recalling conversations or travel details, and changes in judgment or behavior are warning signs that should be evaluated by a specialist.
Medical Arts Neurology also supports families with caregiver programs like GUIDE (for Medicare members) and CARE (for HMO beneficiaries), which include home visits, practical guidance, and emotional support. Participation in community groups and awareness events, such as Alzheimer’s Association walks, is also encouraged.
Finally, families are urged to consider participation in clinical trials—a path that offers access to innovative treatments and contributes to scientific progress in the search for a cure.
Facing Alzheimer’s with information, technology, and support can make a meaningful difference. Consulting with a specialized neurologist is the first step toward making informed decisions and responding in time.
Book an Appointment